Abstract
Matrix metalloproteinases (MMPs) are known to participate in cancer invasion and metastasis. Copious research on MMPs and their inhibitors has promoted the understanding of the mechanisms of cancer invasion and metastasis as well as the development of effective drugs for cancer treatment. This review discusses the classification of MMPs and tissue inhibitors of metalloproteinases (TIMPs) in relation to tumor growth and invasion mechanisms via signal transduction, followed by the possibilities for cancer treatment. The review focuses especially on the development of anti-cancer agents in the field of MMP science.
Keywords: Matrix metalloproteinase (MMP), A disintegrin and metalloproteinase (ADAM), A disintegrin and metalloproteinase with thrombospondin motif (ADAMTS), Tissue inhibitor of metalloproteinases (TIMP), Cancer invasion, Cancer metastasis, Cancer treatment, Anti-cancer agents, cancer cellinvasion, Peptidases.
Anti-Cancer Agents in Medicinal Chemistry
Title:Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream
Volume: 12 Issue: 7
Author(s): Isao Okazaki and Kazuki Nabeshima
Affiliation:
Keywords: Matrix metalloproteinase (MMP), A disintegrin and metalloproteinase (ADAM), A disintegrin and metalloproteinase with thrombospondin motif (ADAMTS), Tissue inhibitor of metalloproteinases (TIMP), Cancer invasion, Cancer metastasis, Cancer treatment, Anti-cancer agents, cancer cellinvasion, Peptidases.
Abstract: Matrix metalloproteinases (MMPs) are known to participate in cancer invasion and metastasis. Copious research on MMPs and their inhibitors has promoted the understanding of the mechanisms of cancer invasion and metastasis as well as the development of effective drugs for cancer treatment. This review discusses the classification of MMPs and tissue inhibitors of metalloproteinases (TIMPs) in relation to tumor growth and invasion mechanisms via signal transduction, followed by the possibilities for cancer treatment. The review focuses especially on the development of anti-cancer agents in the field of MMP science.
Export Options
About this article
Cite this article as:
Okazaki Isao and Nabeshima Kazuki, Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream, Anti-Cancer Agents in Medicinal Chemistry 2012; 12 (7) . https://dx.doi.org/10.2174/187152012802650200
DOI https://dx.doi.org/10.2174/187152012802650200 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Serpins for Diagnosis and Therapy in Cancer
Cardiovascular & Hematological Disorders-Drug Targets A Novel Marine Drug, SZ–685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR–200c
Current Medicinal Chemistry Biomolecules Linked to Transition Metal Complexes - New Chances for Chemotherapy
Current Medicinal Chemistry The Functional Role of Long Non-coding RNA UCA1 in Human Multiple Cancers: a Review Study
Current Molecular Medicine PPARγ in Angiogenesis and Vascular Development
Current Angiogenesis (Discontinued) G4 Aptamers: Trends in Structural Design
Mini-Reviews in Medicinal Chemistry Physical and Chemical Stimuli-Responsive Drug Delivery Systems: Targeted Delivery and Main Routes of Administration
Current Pharmaceutical Design Melatonin Attenuates Methamphetamine-Induced Neurotoxicity
Current Pharmaceutical Design Study of Cancer Cell Lines with Fourier Transform Infrared (FTIR)/ Vibrational Absorption (VA) Spectroscopy
Current Physical Chemistry NCRNA Combined Therapy as Future Treatment Option for Cancer
Current Pharmaceutical Design FDG-PET Imaging in Large Vessel Vasculitis and Polymyalgia Rheumatica: A Personal View
Current Immunology Reviews (Discontinued) Targeted Delivery of Bleomycin: A Comprehensive Anticancer Review
Current Cancer Drug Targets Fluorescent Cisplatin Analogues and Cytotoxic Activity
Current Medicinal Chemistry Editorial
Current Nutrition & Food Science Multiple Myeloma and the Immune Microenvironment
Current Cancer Drug Targets Anti-inflammatory Phytochemicals for Chemoprevention of Colon Cancer
Current Cancer Drug Targets Imaging of Integrins as Biomarkers for Tumor Angiogenesis
Current Pharmaceutical Design Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug
Inflammation & Allergy - Drug Targets (Discontinued) Influence of Pulsing Electromagnetic Field Therapy on Gene Expression in Muscle Cells, Peripheral Circulation, and Metabolic Factors in Aging Adults
Current Chemical Biology Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry